Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · September 06, 2017

First-Line Sunitinib Leads to Radiological Stability in Patients With RCC in VHL Disease

Familial cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Familial cancer
First-Line Sunitinib in Patients With Renal Cell Carcinoma (RCC) in von Hippel-Lindau (VHL) Disease: Clinical Outcome and Patterns of Radiological Response
Fam. Cancer 2015 Jun 01;14(2)309-316, A Roma, M Maruzzo, U Basso, A Brunello, R Zamarchi, E Bezzon, F Pomerri, S Zovato, G Opocher, V Zagonel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading